Dr. Scott Rudge joined the pharma/biotech industry in 1989, and has served as the Chairman/COO of RMC Pharmaceutical Solutions since helping to co-found the company in May 2004 (RMC was acquired by Syner-G BioPharma Group in 2023). Scott has been involved in a wide variety of projects for small and large biotech/pharmaceutical companies, including serving in multiple embedded senior/executive management roles. He has also overseen and/or performed assay, equipment, sterilization, cleaning and process validation, formulation development, due diligence for a multimillion-dollar investment, construction of a new GMP facility for tissue processing, and tech transfer for a major late-stage biotechnology product. In his last full-time position prior to co-founding RMC, Scott served as the Vice President of Operations at FeRx Incorporated, overseeing manufacturing, process and product development, analytical development, formulation, facility design, construction and operation, and intellectual property.
